Inogen Reports Positive Q2 Adjusted EBITDA, Raises Full-Year Guidance, and Repurchases $7.5M in Shares
INGN sits 20% above its 52-week low of $5.34.
Summary
Inogen announced strong Q2 2026 financial results, including positive Adjusted EBITDA and raised full-year guidance, alongside active share repurchases.
Key Events · Earnings and Guidance · INGN
-
Positive Q2 Adjusted EBITDA
Reported positive Adjusted EBITDA of $2.4 million for the second quarter of 2026, a 15.2% increase year-over-year and a significant improvement from the negative Adjusted EBITDA in Q1 2026.
-
Raised Full-Year Adjusted EBITDA Guidance
Increased full-year 2026 Adjusted EBITDA guidance to approximately $4.0 million, representing a 48.1% increase from $2.7 million reported in 2025.
-
Active Share Repurchase Program
Repurchased 1,145,150 shares of common stock for $7.5 million in the first half of 2026 under its previously announced program, demonstrating capital allocation to shareholders.
-
Revenue Growth and International Expansion
Achieved Q2 2026 revenue of $95.1 million, a 3.0% year-over-year increase, driven by strong international revenue growth of 14.8%.
Analysis · INGN · Industrial Applications And Services
Inogen reported a significant turnaround in profitability, achieving positive Adjusted EBITDA of $2.4 million in Q2 2026, a notable improvement from the negative Adjusted EBITDA in the prior quarter. This positive momentum led to a substantial increase in full-year Adjusted EBITDA guidance by 48.1% from 2025 levels. The company also actively repurchased $7.5 million of its common stock in the first half of 2026, signaling management's confidence and commitment to shareholder value.
At the time of this filing, INGN was trading at $6.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $175.7M. The 52-week trading range was $5.34 to $9.13. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.